Scarica l'app Stockscreener
4.665
2.11%
0.095
Macrogenics Inc Borsa (MGNX) Ultime notizie
MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations - The Sun Malaysia
MacroGenics completes sale of manufacturing operations to Bora - Investing.com
MacroGenics sells its drug-making operations to Bora for $122.5M - Stock Titan
MacroGenics (MGNX) Financials 2026Income Statement and Balance Sheet - MarketBeat
Macrogenics | 4: Statement of changes in beneficial ownership of securities-Director O'Brien Federica F. - Moomoo
MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2500 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Value Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Value Benchmark - marketscreener.com
Price to earnings forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to revenue forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Enterprise value to EBITDA forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Enterprise value to EBIT forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to EBIT forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Price to sales forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Price to book forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
MGNX Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics, Inc. Actuals & Estimates (NASDAQ:MGNX) - TradingView
M55 Forecast — Price Target — Prediction for 2027 - TradingView
A1W6ND Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics Inc (MGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX) - Seeking Alpha
MacroGenics To Receive $24.5 Million Milestone From Sanofi For TZIELD Approval - Pulse 2.0
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval - The Manila Times
MacroGenics stock rises on $24.5M Sanofi milestone payment - Investing.com
MacroGenics to receive $24.5M milestone from Sanofi on FDA approval - Investing.com Australia
MacroGenics stock rises on $24.5M Sanofi milestone payment By Investing.com - Investing.com Nigeria
Sanofi (SNY) Drives $24.5M Milestone Payment to MacroGenics - GuruFocus
MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment - marketscreener.com
MacroGenics to Receive $24.5 Million Milestone Payment Following FDA Accelerated Approval of Sanofi’s TZIELD for Children with Stage 3 Type 1 Diabetes - Quiver Quantitative
Sanofi’s TZIELD approval triggers $24.5M payment to MacroGenics - Stock Titan
MacroGenics (MGNX) Gains 4.3% as Shares Test Key Resistance LevelsOrder Block - dars.gov.et
MacroGenics Inc (MGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MacroGenics StockThursday technical snapshot after strong year-to-date rebound - AD HOC NEWS
MacroGenics Inc (MGNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MacroGenics Inc (MGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MacroGenics Inc (MGNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MacroGenics Inc (MGNX) Institutional Confidence - TradingKey
MacroGenics Inc (MGNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
MacroGenics Inc (MGNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MacroGenics Inc Stock (US5562221046): Valuation metrics in focus after recent biotech swing - Ad-hoc-news.de
How The MacroGenics (MGNX) Story Is Shifting With ADC Pipeline Bets And 2026 Data Risks - Yahoo Finance
Millennium Group and Israel Englander report 3.44M MGNX shares (5.4%) - Stock Titan
MacroGenics eyes $200M cash boost, 2028 runway ahead of cancer pipeline updates - MSN
MacroGenics (MGNX) Slips 1.19% as Biotech Stock Tests Key SupportPoint of Control - Město Břeclav
MacroGenics expands ZYNYZ royalty deal with Sagard, secures $60M upfront - MSN
MacroGenics Inc stock (US5562221046): shares ease after strong year-to-date run amid biotech volatil - AD HOC NEWS
Will MacroGenics (MGNX) report negative Q1 earnings? What you should know - MSN
Macrogenics(MGNX) Stock Options Chain | Quotes & News - Moomoo
MacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance
MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates - TradingView
MGNXMacrogenics Inc Stock Price and Quote - Finviz
MacroGenics, Inc. Hits New 52-Week High of $4.64 - Markets Mojo
1.53%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):